دورية أكاديمية

SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease

التفاصيل البيبلوغرافية
العنوان: SGLT2 inhibitor empagliflozin alleviates cardiac remodeling and contractile anomalies in a FUNDC1-dependent manner in experimental Parkinson’s disease
المؤلفون: Yu, WeiAff1, Aff2, Wang, Lin, Ren, Wei-ying, Xu, Hai-xiaAff5, Aff6, Aff7, Wu, Ne N.Aff5, Aff6, Yu, Dong-hui, Reiter, Russel J., Zha, Wen-liangAff1, Aff10, IDs41401023011440_cor8, Guo, Qing-dongAff11, IDs41401023011440_cor9, Ren, JunAff1, Aff5, Aff6, IDs41401023011440_cor10
المصدر: Acta Pharmacologica Sinica. 45(1):87-97
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:16714083
17457254
DOI:10.1038/s41401-023-01144-0